EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Multimorbidity: What Do We Know? What Should We Do?

Rokas Navickas, Vesna-Kerstin Petric, Andrea B Feigl, Martin Seychell

Journal of Comorbidity · 2016-01 · 6 (1) · 4-11

DOI: 10.15256/joc.2016.6.72 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Comorbidity, online erschienen am 17.02.2016. Verfasst von Rokas Navickas und 3 weiteren Autor:innen. Beteiligte Einrichtung: Ministry of Health, Republic of Slovenia, Ljubljana, Slovenia. Die Arbeit wurde bisher 276-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multimorbidity, which is defined as the co-occurrence of two or more chronic conditions, has moved onto the priority agenda for many health policymakers and healthcare providers. Patients with multimorbidity are high utilizers of healthcare resources and are some of the most costly and difficult-to-treat patients in Europe. Preventing and improving the way multimorbidity is managed is now a key priority for many countries, and work is at last underway to develop more sustainable models of care. Unfortunately, this effort is being hampered by a lack of basic knowledge about the aetiology, epidemiology, and risk factors for multimorbidity, and the efficacy and cost-effectiveness of different interventions. The European Commission recognizes the need for reform in this area and has committed to raising awareness of multimorbidity, encouraging innovation, optimizing the use of existing resources, and coordinating the efforts of different stakeholders across the European Union. Many countries have now incorporated multimorbidity into their own healthcare strategies and are working to strengthen their prevention efforts and develop more integrated models of care. Although there is some evidence that integrated care for people with multimorbidity can create efficiency gains and improve health outcomes, the evidence is limited, and may only be applicable to high-income countries with relatively strong and well-resourced health systems. In low- to middle-income countries, which are facing the double burden of infectious and chronic diseases, integration of care will require capacity building, better quality services, and a stronger evidence base.

Schlagwörter

Stichwörter der Autor:innen

European CommissionEuropean UnionICARE4EUJA-CHRODISMultimorbiditySloveniacomorbiditymultiple chronic conditions

Autor:innen und Institutionen

  • Ministry of Health, Republic of Slovenia, Ljubljana, Slovenia.
  • Directorate General for Health and Food Safety, European Commission, Brussels, Belgium.

Zitieren

APA

Navickas, R., Petric, V. K., Feigl, A. B., & Seychell, M. (2016). Multimorbidity: What Do We Know? What Should We Do?. Journal of Comorbidity, 6(1), 4-11. https://doi.org/10.15256/joc.2016.6.72

Vancouver

Navickas R, Petric VK, Feigl AB, Seychell M. Multimorbidity: What Do We Know? What Should We Do?. Journal of Comorbidity. 2016;6(1):4-11. doi:10.15256/joc.2016.6.72

BibTeX
@article{Navickas2016,
  author = {Navickas, Rokas and Petric, Vesna-Kerstin and Feigl, Andrea B and Seychell, Martin},
  title = {Multimorbidity: What Do We Know? What Should We Do?},
  journal = {Journal of Comorbidity},
  year = {2016},
  volume = {6},
  number = {1},
  pages = {4--11},
  doi = {10.15256/joc.2016.6.72}
}
Kostenlos starten →